P/E at 56.44 vs Industry's 54.03: What the Data Shows for Apollo Hospitals Enterprise Ltd.

Valuation Picture: Premium Amidst Sector Norms

The current P/E of 56.44 for Apollo Hospitals Enterprise Ltd. stands at a 4.5% premium over the hospital sector’s average P/E of 54.03. This premium suggests that investors are willing to pay slightly more for the stock relative to its peers, potentially reflecting confidence in its earnings quality or growth prospects. However, the margin is not excessive, indicating that valuation remains broadly in line with sector norms. The market cap of ₹1,05,095.08 crores classifies it firmly as a large-cap stock within the hospital sector, reinforcing its stature and liquidity in the market.

Performance Across Timeframes: Divergent Momentum

Examining the stock’s returns across multiple timeframes reveals a complex momentum profile. Over the past year, Apollo Hospitals Enterprise Ltd. has delivered a positive return of 10.48%, significantly outperforming the Sensex’s negative 5.69% over the same period. This outperformance extends to longer horizons, with three-year returns at 70.73% versus the Sensex’s 27.85%, five-year returns at 150.18% compared to 49.55%, and a remarkable ten-year return of 426.45% against the Sensex’s 190.27%. These figures underscore the stock’s strong long-term growth trajectory.

However, the short-term trend is less encouraging. The stock has declined by 5.30% over the past month, though this is still better than the Sensex’s 10.55% drop. More notably, the one-week performance shows a 2.59% loss, slightly better than the Sensex’s 3.32% decline. The three-month return is positive at 1.92%, contrasting sharply with the Sensex’s 13.89% fall, indicating some resilience in the medium term. This divergence between short-term weakness and medium-to-long-term strength raises questions about the sustainability of recent momentum — is this a temporary pause or a sign of shifting fundamentals?

Moving Average Configuration: Bearish Territory Persists

Technically, Apollo Hospitals Enterprise Ltd. is trading below all key moving averages — the 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This configuration typically signals a bearish trend or at least a period of consolidation after a prior uptrend. The stock’s inability to breach these averages suggests that short-term rallies may face resistance, and the broader downtrend remains intact. The recent intraday high of ₹7,320.95, achieved with a 2.49% gain today, indicates some buying interest, but the overall technical picture remains cautious — is this a genuine recovery or a dead-cat bounce? — the moving average configuration provides the clearest answer.

Relative Performance vs Sensex: Consistent Outperformance

Across all meaningful timeframes, Apollo Hospitals Enterprise Ltd. has consistently outperformed the Sensex. The year-to-date return of 3.79% contrasts with the Sensex’s 13.70% decline, while the three-month and one-month returns also show relative strength. Even on a daily basis, the stock’s 2.32% gain outpaces the Sensex’s 1.17% rise. This relative resilience highlights the stock’s defensive qualities within the hospital sector, which itself gained 2.49% today. However, the recent weekly loss of 2.59% versus the Sensex’s 3.32% decline suggests some short-term profit-taking or sector rotation.

Sector Context: Hospital Industry Showing Mixed Signals

The hospital sector has experienced a mixed performance profile recently, with 2.49% gains today signalling some recovery after a period of volatility. Within this context, Apollo Hospitals Enterprise Ltd. remains a dominant player, benefiting from its large-cap status and diversified operations. The sector’s average P/E of 54.03 reflects moderate valuation levels, with some stocks trading at premiums or discounts depending on their growth outlook and earnings stability. The sector’s recent performance suggests cautious optimism, but investors remain watchful of broader macroeconomic factors affecting healthcare demand and costs.

Rating Context: Previously Rated Buy, Now Reassessed

MarketsMOJO had previously assigned a Buy rating to Apollo Hospitals Enterprise Ltd., but this was updated to Hold on 09 Jan 2026. The reassessment reflects the evolving valuation-performance dynamics and the technical signals outlined above. The current Mojo Score stands at 55.0, indicating a moderate stance. This shift invites investors to reconsider their positions — should investors in Apollo Hospitals hold, buy more, or reconsider?

Conclusion: Data Reflects a Stock at a Crossroads

The data for Apollo Hospitals Enterprise Ltd. paints a picture of a large-cap hospital stock trading at a modest premium to its sector, with strong long-term returns but recent short-term volatility and technical weakness. The stock’s position below all major moving averages signals caution, despite its resilience relative to the Sensex and sector peers. The rating update from Buy to Hold underscores this nuanced outlook, suggesting that while the company remains fundamentally strong, investors should weigh the recent momentum shifts carefully — what is the current rating?

Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today